Abstract
Hepatic Encephalopathy (HE) is a serious neuropsychiatric complication of both acute and chronic liver failure. A study group concluded in 2002 that “HE is a spectrum of neuropsychiatric abnormalities seen in patients with liver dysfunction after exclusion of other known brain diseases” (Ferenci et al., 2002). A multiaxial definition of HE was proposed that defines both the type of hepatic abnormality and the characteristics of the neurological manifestations. Three types of hepatic abnormalities were defined, namely:
Keywords
- Glial Fibrillary Acidic Protein
- Hepatic Encephalopathy
- Cirrhotic Patient
- Acute Liver Failure
- Hepatic Coma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adams RD, Foley JM. The neurological disorder associated with liver disease. In: Metabolic and Toxic Diseases of the Nervous System. (H.H. Merritt, and C.C. Hare, eds.)Vol. 32. Williams and Wilkins, Baltimore, USA, pp. 198-237, 1953
Ahboucha S, Butterworth RF. The neurosteroid system: Implication in the pathophysiology of hepatic encephalopathy. Neurochem. Int., 52, 575-587, 2008
Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann. Neurol., 58, 169-170, 2005
Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, Halliwell RF. An interaction between benzodiazepines and neuroactive steroids at GABAA receptors in cultured hippocampal neurons. Neurochem. Int., 48, 703-707, 2006
Bates TE, Williams SR, Kauppinen RA, Godian DG. Observation of cerebral metabolites in an animal model of ALF in vivo: 1H and 31P nuclear magnetic resonance study. J. Neurochem., 53, 102-110, 1989
Bélanger M, Desjardins P, Chatauret N, Butterworth RF. Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem. Int., 41(2-3), 155-160, 2002
Bélanger M, Ahboucha S, Desjardins P, Butterworth RF. Upregulation of peripheral-type (mitochondrial) benzodiazepine receptors in hyperammonemic syndromes: Consequences for neuronal excitability. Adv. Mol. Cell Biol., 31(3), 983-997, 2004
Bélanger M, Desjardins P, Chatauret N, Butterworth RF. Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure (p NA). Glia, 53(5), 557-562, 2006
Bender AS, Schousboe A, Reichelt W, Norenberg MD. Ionic mechanisms in glutamate-induced astrocyte swelling: Role of K+ influx. J. Neurosci. Res., 52, 307-321, 1998
Bengtsson F, Bugge M, Johansen KH, Butterworth RF. Brain tryptophan hydroxylation in the portacaval shunted rat: A hypothesis for the regulation of serotonin turnover in vivo. J. Neurochem., 56, 1069-1074, 1991
Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res., 14, 853-859, 1989
Bergeron M, Swain MS, Reader TA, Grondin L, Butterworth RF. Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J. Neurochem., 55, 222-229, 1990
Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res., 20, 79-86, 1995
Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J. Hepatol., 40, 327-330, 2004
Bosman DK, van den Buijs CA, de Haan JG, Maas MA, Chamuleau RA. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Gastroenterology, 101, 772-781, 1991
Bosman DK, Deutz NEP, Maas MAW, van Eijk MHH, Smit JJH, de Haan JG, Chamuleau RAFM. Amino acid release from cerebral cortex in experimental ALF, studied by in vivo cerebral cortex microdialysis. J. Neurochem., 59, 591-599, 1992
Butterworth RF. Hepatic encephalopathy and brain edema in acute hepatic failure: Does glutamate play a role. Hepatology, 25, 1032-1034, 1997
Butterworth RF. Neurotransmitter dysfunction in hepatic encephalopathy: New approaches and new findings. Metab. Brain Dis., 16, 55-65, 2001
Butterworth RF. Neuronal cell death in hepatic encephalopathy. Metab. Brain Dis., 22, 309-320, 2007
Butterworth RF, Giguère JF. Cerebral amino acids in portal-systemic encephalopathy: Lack of evidence for altered γ-aminobutyric acid (GABA) function. Metab. Brain Dis., 1, 221-228, 1986
Butterworth RF, Giguère JF, Michaud J, Lavoie J, Pomier Layrargues G. Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol., 6, 1-12, 1987
Butterworth RF, Lavoie J, Giguère JF, Pomier Layrargues G. Affinities and densities of high affinity 3H-muscimol (GABA-A) binding sites and central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology, 8, 1084-1088, 1988
Butterworth RF, Tonon MC, Désy L, Giguère JF, Vaudry H, Pelletier G. Increased brain content of the endogenous benzodiazepine receptor ligand octadecaneuropeptide (ODN) following portacaval anastomosis in the rat. Peptides, 12, 119-125, 1991
Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo quantification of cerebral “peripheral benzodiazepine binding site” in minimal hepatic encephalopathy: A [11C]R-PK11195 positron emission tomography study. J. Hepatol., 34, 58, 2001
Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: Its pros and cons. Ther. Apher. Dial., 10(2), 168-174, 2006
Chan H, Hazell AS, Desjardins P, Butterworth RF. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int., 37, 243-248, 2000
Chatauret N, Butterworth RF. Effects of liver failure on inter-organ trafficking of ammonia: Implications for the treatment of encephalopathy. J. Gastroenterol. Hepatol., 19, S219-S223, 2004
Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with ALF is correlated with arterial ammonia concentration. Hepatology, 29, 648-653, 1999
Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology, 27(2), 339-345, 1998
Desjardins P, Butterworth RF. The “peripheral-type” benzodiazepine (ω 3) receptor in hyperammonemic disorders. Neurochem. Int., 41, 109-114, 2002
Desjardins P, Bandeira P, Raghavendra Rao VL, Ledoux S, Butterworth RF. Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein in mRNA brain following portacaval anastomosis. Brain Res., 758, 255-258, 1997
Desjardins P, RamaRao VK, Michalak A, Rose C, Butterworth RF. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle. Metab. Brain Dis., 14, 273-282, 1999
Devenyi AG, Barron TF, Mamourian AC. Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagilles’s syndrome. Gastroenterology, 106, 1068-1071, 1994
DeWaele JP, Audet RM, Leong DK, Butterworth RF. Portacaval anastomosis results in region-selective changes of β-endorphin content and of μ and δopiod receptor densities in rat brain. Hepatology, 24, 895-901, 1996
DeWaele JP, Audet RM, Rose C, Butterworth RF. The portacaval-shunted rat: A new model for the study of the mechanisms controlling voluntary ethanol consumption and ethanol dependence. Alcohol Clin. Exp. Res., 21, 305-310, 1997
Felipo V, Butterworth RF. Neurobiology of ammonia. Prog. Neurobiol., 67, 259-279, 2002
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT, and the Members of the Working Party. Hepatic encephalopathy - definition, nomenclature, diagnosis and quantification: Final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology, 35, 716-721, 2002
Gabuzda G Jr., Philips GB, Davidson CS. Reversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resins. New Engl. J. Med., 246, 124-130, 1952
Ganda OP, Ruderman NB. Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism, 25(4), 427-435, 1976
Gentile S, Guarino G, Romano M, Alagia IA, Fierro M, Annunziata S, Magliano PL, Gravina AG, Torella R. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin. Gastroenterol. Hepatol., 3, 184-191, 2005
Giguère JF, Hamel E, Butterworth RF. Increased densities of binding sites for the “peripheral-type” benzodiazepine receptor ligand 3H-PK11195 in rat brain following portacaval anastomosis. Brain Res., 585, 295-298, 1992
Girard G, Giguère JF, Butterworth RF. Effect of portacaval anastomosis on ammonia metabolism in brain and liver. In: Hepatic Encephalopathy: Pathophysiology and Treatment. (R.F. Butterworth, and G. Pomier Layrargues, eds.), Humana Press, New Jersey., pp. 79-89, 1989
Gyr K, Meier R Haussler J, Bouletreau P, Fleig WE, Gatta A, Holstege A, Pomier Layrargues G, Schalm SW, Groeneweg M, Scollo-Lavizzari G, Ventura E, Zeneroli ML, Williams R, Yoo Y, Amrein R. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: A double blind, randomised, placebo controlled multicentre study. Gut, 39, 319-324, 1996
Haefely WE. Allosteric modulation of the GABAA receptor channel: A mechanism for interaction with a multitude of central nervous system function. In: The Challenge of Neuropharmacology. (H. Möhler, and M. Da Prada, eds.), F. Hoffman-La Roche , Basel, Switzerland, pp. 15-40, 1994
Hindfelt B, Plum F, Duffy TE. Effects of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J. Clin. Invest., 59, 386-396, 1977
Huet PM, Pomier Layrargues G, Duguay L, Du Souich P. Blood—brain barrier transport of tryptophan and phenylalanine: Effect of portacaval shunt in dogs. Am. J. Physiol., 4, 163-169, 1981
Jacobs EH, Yamatodani A, Timmerman H. Is histamine the final neurotransmitter in the entrainment of circadian rhythms in mammals. Trends Pharmacol. Sci., 21(8), 293-298, 2000
Jalan R, Damink SW, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet, 354(9185), 1164-1168, 1999
Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in ALF. J. Hepatol., 37, 536-538, 2002
Keiding S, SØrensen M, Bender D, Munk OL, Ott P, Vilstrup H. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology, 43, 42-50, 2006
Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R, Kruger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rosch W, Stauch S. Therapeutic efficacy of l-ornithine-l-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. Hepatology, 25(6), 1351-1360, 1997
Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with ALF. Neurosci. Lett., 229, 201-203, 1997
Kosenko E, Kaminsky Y, Grau E, Minana MD, Grisolia S, Felipo V. Nitroarginine an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem. Res., 20(4), 451-456, 1995
Kril JJ, Butterworth RF. Diencephalic and cerebellar pathology in alcoholic and non-alcoholic patients with end-stage liver disease. Hepatology, 24(4), 1303, 1996
Lai JCK, Cooper AJL. Brain α-ketoglutarate dehydrogenase: Kinetic properties, regional distribution and effects of inhibitors. J. Neurochem., 47, 1376-1386, 1986
Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J. Hepatol., 34(4), 548-554, 2001
Laubenberger J, Haussinger D, Boyer S, Guffer H, Henning J, Lange M. Proton magnetic resonance spectroscopy of brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology, 112, 1610-1616, 1997
Lavoie J, Giguère JF, Pomier Layrargues G, Butterworth RF. Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy. Metab. Brain Dis., 2, 283-290, 1987a
Lavoie J, Giguère JF, Pomier Layrargues G, Butterworth RF. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem., 49, 692-697, 1987b
Lavoie J, Pomier Layrargues G, Butterworth RF. Increased densities of “peripheral-type” benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology, 11, 874-878, 1990
Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology, 39(5), 1441-1449, 2004
Lockwood AH, Yap EWH, Wong W-H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab., 11, 337-341, 1991
Lockwood AH, Weissenborn K, Butterworth RF. An image of the brain in patients with liver disease. Curr. Opin. Neurol., 10, 525-533, 1997
Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in non-alcoholic cirrhotics. Metab. Brain Dis., 17, 29-40, 2002
Lozeva V, Valjakka A, Lecklin A, Olkkonen H, Hippelainen M, Itkonen M, Plumed C, Tuomisto L. Effects of the histamine H(1) receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis. Hepatology, 31(2), 336-344, 2000
Lozeva V, Montgomery JA, Tuomisto L, Rochelean B, Pannunzio M, Huet PM, Butterworth RF. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J. Hepatol., 40, 742-748, 2004
Lozeva-Thomas V, Ahonen P, Chatauret N, Tuomisto L, Butterworth RF. Brain histamine in experimental acute liver failure: Effects of l-histidine loading. Inflamm. Res., 53(Suppl. 1), S55-S56, 2004
Maddison JE, Watson WEJ, Dodd PR, Johnston GAR. Alterations in cortical 3H-kainate and α-3H-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy. J. Neurochem., 56, 1881-1888, 1991
Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, Liborio R. Effects of l-carnitine in patients with hepatic encephalopathy. World J. Gastroenterol., 11(45), 7197-7202, 2005
Mans AM, Kukulka KM, McAvoy KJ, Rokosz NC. Regional distribution and kinetics of three sites on the GABAA receptor: Lack of effect of portacaval shunting. J. Cereb. Blood Flow Metab 12, 334-346, 1992
Mans AM, De Joseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J. Neurochem., 63, 1829-1838, 1994
McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA, 89, 3170-3174, 1992
Mena EE, Cotman CW. Pathologic concentrations of ammonium ions block l-glutamate uptake. Exp. Neurol., 59, 259-263, 1985
Michalak A, Butterworth RF. Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failure. Hepatology, 24, 631-635, 1997
Michalak A, Rose C, Butterworth J, Butterworth RF. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology, 24, 908-913, 1996
Mirowitz SA, Westrich TJ, Hirsch JD. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology, 191, 117-120, 1991
Mollace V, Colasanti M, Rodino P, Lauro GM, Rotiroti D, Nistico G. NMDA-dependent prostaglandin E2 release by human cultured astroglial cells is driven by nitric oxide. Biochem. Biophys. Res. Commun., 215, 793-799, 1995
Moroni F, Lombardi G, Carla V, Pellegrini D, Carassale GL, Cortesini C. Content of quinolinic acid and other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J. Neurochem., 46, 869-874, 1986a
Moroni F, Lombardi G, Carla V, Lal S, Etienne P, Nair NPV. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J. Neurochem., 47, 1667-1671, 1986b
Mossakowski MJ, Renkawek K, Krasnicka Z, Smialek M, Pronaszko A. Morphology and histochemistry of Wilsonian and hepatogenic gliopathy in tissue culture. Acta Neuropathol., 16, 1-16, 1970
Mousseau DD, Perney P, Pomier Layrargues G, Butterworth RF. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci. Lett., 162, 192-196, 1993
Mousseau DD, Pomier Layrargues G, Butterworth RF. Region-selective decreases in densities of [3H]-tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem., 61, 621-625, 1994
Mousseau DD, Baker GB, Butterworth RF. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J. Neurochem., 68, 1200-1208, 1997
Mullen KD, Szauter KM, Kaminsky-Russ K. “Endogenous” benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet, 336, 81-83, 1990
Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H. High levels of serum interleukin-10 and tumor necrosis factor-α are associated with fatality in fulminant hepatitis. J. Infect. Dis., 182, 1103-1108, 2000
Neary JT, Whittemore SR, Zhu Q, Norenberg MD. Destabilization of glial fibrillary acidic protein mRNA in astrocytes by ammonia and protection by extracellular ATP. J. Neurochem., 63(6), 2021-2027, 1994
Norenberg MD. The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol., 6, 13-33, 1987
Norenberg MD, Lapham LW. The astrocyte response in experimental portal-systemic encephalopathy: An electron microscope study. J. Neuropathol. Exp. Neurol., 33, 422-435, 1974
Norenberg MD, Huo Z, Neary JT, Roig-Cantesano A. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: Relation to energy metabolism and glutamatergic neurotransmission. Glia, 21(1), 124-133, 1997
Olasmaa M, Rothstein JD, Guidotti A, Weber RJ, Paul SM, Spector S, Zeneroli ML, Baraldi M, Costa E. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem., 55, 2015-2023, 1990
Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, Jalan R. Interorgan ammonia metabolism in liver failure. Neurochem. Int., 41(2-3), 177-188, 2002
Oppong KNW, Bartlett K, Record CO, Al Mardini H. Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat. Hepatology, 22, 553-558, 1995
Panerai AE, Salerno F, Baldissera F, Martini A, Di Giulio AM, Mantegazza P. Brain β-endorphin concentrations in experimental chronic liver failure. Brain Res., 247, 188-190, 1982
Peterson C, Giguère JF, Cotman CW, Butterworth RF. Selective loss of N-methyl-D-aspartate-sensitive l-3H-glutamate binding sites in rat brain following portacaval anastomosis. J. Neurochem., 55, 386, 1990
Pomier Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF. Clinical efficacy of benzodiazepine antagonist RO 15—1788 (flumazenil) in cirrhotic patients with hepatic coma: Results of a randomized double-blind placebo-controlled cross-over trial. Hepatology, 19, 32-37, 1994
Pomier Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients: Cause of magnetic resonance hyperintensity. Lancet, 345, 735, 1995
Porter JT, McCarthy KD. GFAP-positive hippocampal astrocytes in situ respond to glutamatergic neuroligands with increases in [Ca2+]i. Glia, 13, 101-112, 1995
Raabe W. Synaptic transmission in ammonia intoxication. Neurochem. Pathol., 6, 145-166, 1987
Raghavendra Rao VL, Butterworth RF. Alterations of [3H]8-OH-DPAT and [3H]-ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci. Lett., 182, 69-72, 1994
Raghavendra Rao VL, Audet RM, Butterworth RF. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: Results of an in vivo microdialysis study. J. Neurochem., 65, 1221-1228, 1995
Raghavendra Rao VL, Audet RM, Butterworth RF. Increased neuronal nitric oxide synthase expression in brain following portacaval anastomosis. Brain Res., 765, 169-172, 1997
Rama Rao VK, Desjardins P, Rose C, Therrien G, Butterworth RF. Increased glutamine synthetase expression in skeletal muscle: An important alternative pathway for ammonia removal in liver failure. Hepatology, 30(4), 162A, #7, 1999
Rose C, Michalak A, Pannunzio P, Therrien G, Quack G, Kircheis G, Butterworth RF. L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: Therapeutic efficacy and mechanism of action. Metab. Brain Dis., 13(2), 24-32, 1998
Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Spahr L, Huet P-M, Pomier Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology, 117, 640-644, 1999
Rose C, Kresse W, Kettenmann H. Acute ammonia insult results in calcium-dependent glutamate release from cultured astrocytes: An effect of pH. J. Biol. Chem., 280(22), 20937-20944, 2005
Rothstein JD, McKhann G, Guarneri P, Barbaccia ML, Guidotti A, Costa E. Hepatic encephalopathy and cerebrospinal fluid content of diazepam binding inhibitor (DBI). Ann. Neurol., 26, 57-62, 1989
Rovira A, Cordoba J, Sanpedro F, Grive E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology, 59, 335-341, 2002
Roy S, Pomier Layrargues G, Butterworth RF, Huet PM. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: Lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase and brain postsynaptic GABA receptors. Hepatology, 8, 845-849, 1988
Schafer DF, Jones EA. Hepatic encephalopathy and the γ-aminobutyric acid system. Lancet, 1, 18-20, 1982
Schliess F, Görg B, Fischer R, Desjardins P, Bidmon HJ, Herrmann A, Butterworth RF, Zilles K, Häussinger D. Ammonia induces MK-801 sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J., 16(7), 739-741, 2002
Schmidt W, Wolf G, Grungreiff K, Meier M, Reum T. Hepatic encephalopathy influences high affinity uptake of transmitter glutamate and aspartate into the hippocampal formation. Metab. Brain Dis., 5, 19-32, 1990
Sharief MK, Thompson EJ. In vivo relationship of tumor necrosis factor-α to blood—brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol., 38(1-2), 27-33, 1992
Shiraishi T, Black KL, Ikesaki K. Peripheral benzodiazepine receptor ligands induce morphological changes in mitochondria of cultured glioma cells. Soc. Neurosci. Abs., 16, 214-216, 1990
Sobel RA, De Armond SJ, Forno LS, Eng LF. Glial fibrillary acidic protein in hepatic encephalopathy: An immunohistochemical study. J. Neuropathol. Exp. Neurol., 40, 625-632, 1981
Sonnewald U, Therrien G, Butterworth RF. Portal-systemic encephalopathy, disorder of neuron-astrocytic metabolic trafficking: Evidence from 13C-NMR studies. J. Neurochem., 67, 1711-1717, 1996
Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Millette P, Lebrun L-H, Zayed J, Leblanc A, Pomier Layrargues G. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology, 24, 1116-1120, 1996
Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: A randomized controlled pilot trial. Am. J. Gastroenterol., 202, 744-753, 2007
Staub F, Baethmann A, Peters J, Weight H, Keupski O. Effects of lactacidosis on glial cell volume and viability. J. Cereb. Blood Flow Metab., 10, 866-876, 1990
Swain MS, Bergeron M, Audet R, Blei AT, Butterworth RF. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter. A comparison of two rodent models of fulminant hepatic failure. Hepatology, 16, 1028-1035, 1992
Szerb JC, Butterworth RF. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog. Neurobiol., 39, 135-153, 1992
Tasaka K. New advances in histamine research. Spinger, Tokyo, 1994
Therrien G, Giguère JF, Butterworth RF. Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy. Metab. Brain Dis., 6, 225-231, 1991
Therrien G, Butterworth J, Rose C, Butterworth RF. Protective effect of l-carnitine in ammonia-precipitated encephalopathy in portacaval shunted rats: Evidence for a central mechanism of action. Hepatology, 25, 551-556, 1997
Thornton JR, Losowsky MS. Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis. Br. Med. J., 297, 1241-1242, 1988
Tominaga S, Watanabe A, Tsuji T. Synergistic effect of bile acid, endotoxin, and ammonia on brain edema. Metab. Brain Dis., 6(2), 93-105, 1991
Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology, 125, 755-764, 2003
Vaquero J, Rose C, Butterworth RF. Keeping cool in acute liver failure: Rationale for the use of mild hypothermia. J. Hepatol., 43, 1067-1077, 2005
Vaquero J, Bélanger M, James L, Herrero R, Desjardins P, Cote J, Blei AT, Butterworth RF. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology, 132(1), 372-383, 2007
Verkhratsky A, Kirchhoff F. NMDA receptors in glia. The Neuroscientist, 13(1), 28-37, 2007
Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology, 25, 820-827, 1997
Weber FL Jr, Veach GL. The importance of the small intestine in gut ammonium production in the fasting dog. Gastroenterology, 77, 235-240, 1979
Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology, 19, 1407-1413, 1994
Yao H, Sadoshima S, Fujii K, Kusada K, Ishitsuka T, Tamaki K, Fujishima M. Cerebrospinal fluid lactate in patients with hepatic encephalopathy. Eur. Neurol., 27, 182-187, 1987
Young SN, Lal S. CNS tryptamine metabolism in hepatic coma. J. Neural. Transm., 47, 153-161, 1980
Young SN, Lal S, Feldmuller F, Aranoff A, Martin JB. Relationships between tryptophan in serum and CSF and 5-hydroxyindoleacetic acid in CSF of man: Effects of cirrhosis of the liver and probenecid administration. J. Neurol. Neurosurg. Psychiat., 38, 322-330, 1975
Yurdaydin C, Gu ZQ, Nowak G, Fromm C, Holt AG, Basile AS. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: Relationship between brain concentration and severity of encephalopathy. J. Pharmacol. Exp. Ther., 265, 565-571, 1993
Zwingmann C, Desjardins P, Chatauret N, Michalak A, Hazell AS, Butterworth RF. Reduced astrocytic glycine transporter Glyt-1 in acute liver failure. Metab. Brain Dis., 17(4), 263-274, 2002
Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF. Selective increase of brain lactate synthesis in experimental acute liver failure: Results of a [1H-13C] nuclear magnetic resonance study. Hepatology, 37, 420-428, 2003
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Butterworth, R.F. (2009). Pathophysiology of Hepatic Encephalopathy: Studies in Animal Models. In: McCandless, D. (eds) Metabolic Encephalopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79112-8_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-79112-8_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79109-8
Online ISBN: 978-0-387-79112-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)